Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
(4)
About
Alivus Life Sciences Ltd.
NSE: ALIVUS
|
BSE: 543322
|
ISIN: INE03Q201024
|
Industry: Pharmaceuticals
5-year high
|
Strong Performer, Getting Expensive
1374.5000
44.70
(
3.36
%)
NSE
Aug 10, 2026
15:31 PM
New 52W High today
Volume:
342.7K
High vol.+gain this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alivus Life Sciences Ltd.
16 Jul 2024
5-year high
1374.50
3.36%
Glenmark Life Sciences Ltd
Buy:
Alivus Life Sciences Ltd.
by
Hem Securities
Target: 987
Hem Securities
Alivus Life Sciences has gained
20.26%
in the last 1 Month
More from Alivus Life Sciences Ltd.
Recommended
IPO market gets crowded as Shiprocket and Milky Mist lead the next wave
|
10 Aug 2026, 05:40PM
Market closes flat as uncertainty over US-Iran deal keeps investors cautious
Trendlyne Marketwatch |
10 Aug 2026, 04:03PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
|
27 Jul 2021